What Happened?
Boston, MA-based NuProbe Appointed Chai Yingshuang as Co-Founder and Chief Executive Officer
About the Company
NuProbe brings together cutting-edge innovations in molecular engineering with leading scientific expertise and management to take on one of the world`s greatest challenges — non-invasive early detection of rare genetic variants in patients. NuProbe will take a multi-platform approach to apply these breakthrough technology capabilities in precision medicine to cancer diagnostics, NIPT, and infectious disease screening, building on scientific findings licensed by Wyss Institute, Harvard University.
About the Person
Chai Yingshuang is Co-Founder and Chief Executive Officer at NuProbe. Previously, Chai held various senior HR leadership roles in the industry.
Info Source
News
Short Profile